¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nuclear proliferation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® nuclear medicine ÇÑ±Û ÇÙÀÇÇÐ
¼³¸í   
  ¹æ»ç¼ºÀ» ¶ì´Â ÇÙ¹°ÁúÀ» ÀÌ¿ëÇÏ¿© ÀÇÇп¡ ÀÀ¿ëÇϴ Çй®. ´ë°³ ÀÎü¿¡ Å« Çذ¡ ¾ø´Â ¹æ»ç¼±¹°ÁúÀ» »ç¿ëÇϸç, ¹Ý°¨±â°¡ Âª¾Æ »ç¿ëÈÄ¿¡µµ Å« Çذ¡ ¾ø´Ù. ÀÌ·± ÇÙÀÇÇÐÀû ¹°ÁúÀ» ÀÌ¿ëÇÑ ÇÙÀÇÇÐÀû Áø´ÜÀÇ °¡Àå Å« ÀåÁ¡Àº »ýü³»¿¡¼­ ÀϾ´Â ±× ±â°üÀÇ ½ÇÁ¦ÀûÀΠ±â´ÉÀ» ¾Ë¾Æº¼ ¼ö Àִٴ µ¥ ÀÖ´Ù. ÈçÈ÷ Á¢Çϴ X-¼±À» ÀÌ¿ëÇÑ Áø´Ü¹æ¹ýÀº ´ÜÁö ±× ¼ø°£¸¸ÀÇ ¿µ»óÀ» Á¢ÇÏ¿© ½ÇÁ¦·Î º¸À̴ ºÎÀ§°¡ ¾ó¸¶³ª ±â´ÉÀ» ¼öÇàÇÏ´ÂÁö ¾Ë ¼ö ¾ø´Â ´ÜÁ¡ÀÌ ÀÖÀ¸³ª, ÇÙÀÇÇп¡¼­´Â ½ÇÁ¦ÀûÀΠ±â´ÉÀÇ Á¤µµ¿¡ µû¶ó ¿µ»óÀÌ ³ª¿À°Ô µÇ¹Ç·Î ±â´ÉÆÇº°¿¡ ¾ÆÁÖ À¯¸®ÇÏ´Ù. ÇÏÁö¸¸, Á¤È®ÇÑ ÆÇº°·ÂÀÌ Àִ ¿µ»óÀ» ¾ò±â¿¡´Â ºÎÁ·ÇÏ´Ù.
  
  ¶ÇÇÑ ÇÙÀÇÇÐÀº Áø´Ü¿ÜÀÇ Ä¡·á¿¡µµ »ç¿ëµÇ´Âµ¥, ¿¹¸¦ µé¾î °©»ó»ùÁ¾¾çÀÇ °æ¿ì ¿©·¯ °÷¿¡ À̹̠ÀüÀ̰¡ µÇ¾î ÀÖÀ» °æ¿ì ¹æ»ç¼±ÇÙÁ¾À» ÀÌ¿ëÇÏ¿© ´Ù¸¥ °÷¿¡ Å« ºÎÀÛ¿ë¾øÀÌ Ä¡·á°¡ °¡´ÉÇÏ´Ù.
¿µ¹® nuclear magnetic resonance(NMR) ÇÑ±Û ÇÙÀÚ±â°ø¸í
¼³¸í   
  ´Ù¸¥ ¸»·Î MRI=Magnetic Resonance Imaging ÀÚ±â°ø¸í¿µ»óÀ̶ó°íµµ ÇÑ´Ù. ÀÎüÀÇ Àå±â³ª, º´ÀûÀΠ¸ð¾ç, Á¾¾çÀÇ À§Ä¡, ¸²ÇÁÀýÀÇ ºñ´ë µî¿¡ ´ëÇÑ Áø´ÜÀ» ³»¸®±â À§ÇØ ½ÃÇàÇϴ ¹æ»ç¼±ÇÐÀûÀΠ°Ë»ç¹æ¹ýÀÌ´Ù. ÇöÀç ¸¹ÀÌ ¾²À̰í Àִ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT=computerized tomography)°ú´Â ´Ù¸¥ ¹æ¹ýÀ¸·Î ½ÃÇàÇϸç, ±× Çػ󵵰¡ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù´Â ¶Ù¾î³ª ºñ·Ï °í°¡À̱ä ÇÏÁö¸¸, ¸¹ÀÌ ¾²À̰í ÀÖ´Ù. ¶ÇÇÑ ÀÎü¿¡ ¹«ÇØÇϰí, ¿©·¯ °¡Áö ¸é(plane)¿¡¼­ »ç¶÷À» ´ÜÃþ½ÃÄÑ º¼ ¼ö ÀÖ´Ù. ´ÜÁ¡Àº ½ÉÀå¹Úµ¿±â¸¦ ¼³Ä¡ÇÑ »ç¶÷À̳ª, ÁÖÀ§¿¡ ÀÚÀåÀ» ¶ì´Â ¹°Ã¼¸¦ ¸ö¿¡ Áö´Ï°í Àִ ÁßȯÀÚ µî¿¡¼­´Â ÀÌ¿ëÇÒ ¼ö ¾ø°í, º¹ºÎÀå±â¿¡ ´ëÇÑ Áø´Ü¿¡´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù ¶³¾îÁö´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior hyaloid fibrovascular proliferation
    ¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
  • proliferation
    Áõ½Ä
  • proliferation zone
    Áõ½ÄÃþ
  • pseudoepitheliomatous proliferation
    °ÅÁþ»óÇÇÁ¾¼ºÁõ½Ä
  • pseudosarcomatous proliferation
    °ÅÁþÀ°Á¾Áõ½Ä, °¡¼ºÀ°Á¾Áõ½Ä
  • autonomous nuclear family
    ÀÚÀ²ÇÙ°¡Á·
  • nuclear bag
    ÇÙÁÖ¸Ó´Ï
  • nuclear bag fiber
    ÇÙÁָӴϼ¶À¯, ÇÙÁָӴϱÙ(À°)¼¼Æ÷
  • nuclear bombardment
    ÇÙÃæ°Ý
  • nuclear cardiology
    ½ÉÀåÇÙÀÇÇÐ
  • nuclear chain
    Çٻ罽
  • nuclear chain fiber
    Çٻ罽¼¶À¯, Çٻ罽±Ù(À°)¼¼Æ÷
  • nuclear dust
    ÇÙ¸ÕÁö
  • nuclear energy
    ÇÙ¿¡³ÊÁö
  • nuclear envelope
    ÇÙ¸·, ÇÙÇǸ·
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferation
    Áõ½Ä
  • nuclear membrane
    ÇÙ¸·
  • nuclear magnetic resonance
    ÇÙÀÚ±â°ø¸í
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior hyaloid fibrovascular proliferation
    ¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
  • proliferation
    Áõ½Ä
  • proliferation zone
    Áõ½ÄÃþ
  • pseudoepitheliomatous proliferation
    °ÅÁþ»óÇÇÁ¾¼ºÁõ½Ä
  • pseudosarcomatous proliferation
    °ÅÁþÀ°Á¾¼ºÁõ½Ä, °¡¼ºÀ°Á¾Áõ½Ä
  • autonomous nuclear family
    ÀÚÀ²ÇÙ°¡Á·
  • nuclear bag
    ÇÙÁÖ¸Ó´Ï
  • nuclear bombardment
    ÇÙÃæ°Ý
  • nuclear cardiology
    ½ÉÀåÇÙÀÇÇÐ
  • nuclear chain
    Çٻ罽
  • nuclear dust
    ÇÙ¸ÕÁö
  • nuclear energy
    ÇÙ¿¡³ÊÁö
  • nuclear envelope
    ÇÙ¸·
  • nuclear feeling
    Çٽɰ¨Á¤
  • nuclear fission
    Çٺп­
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior hyaloid fibrovascular proliferation
    ¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
  • proliferation phase
    Áõ½Ä±â(ñòãÖÑ¢).
  • proliferation zone
    Áõ½ÄÃþ
  • reactive pseudosarcomatous proliferation
    ¹ÝÀÀ¼º °¡¼ºÀ°Á¾¼º Áõ½Ä(¡­Ê£àõë¿ðþàõ)
  • EB nuclear antigen(EBNA0
    EB ¹ÙÀÌ·¯½º ÇÙÇ׿ø
  • EB nuclear antigen (EBNA)
    EB¹ÙÀÌ·¯½º ÇÙÇ׿ø
  • anti-extractable nuclear antigen
    Ç×-ÃßÃ⼺ ÇÙÇ׿ø
  • anulus of nuclear pore
    ÇÙ±¸¸ÛµÑ·¹
  • hypochromatosis =nuclear solution
    (ÇÙ)¿°Áú°¨¾à(ú·æøòõÊõå°) ÇÙºØA , ÇǺλö¼ÒÄ§Âø°¨¼ÒÁõ(ù«Ý±ßäáÈ ó·Êõá´ñø).
  • inner nuclear layer
    ³»ÇÙÃþ(Ò®ú·öµ).
  • inner nuclear layer
    ¼ÓÇÙÃþ
  • inner nuclear layer
    ³»°ú¸³Ãþ(Ò®öµ), ¼ÓÇÙÃþ.
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ.
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ ÇÙ¼º ¾È±Ù¸¶ºñ(òäú¼àõ ú·àõ äÑÐÉØ¦Ýö)
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nuclear proliferation =nucleosis
    ÇÙÁõ½Ä(ú·ñòãÖ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior hyaloid fibrovascular proliferation
    ¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
  • atherosclerosis,intimal smooth muscle proliferation
    ³»¸·ÆòȰ±Ù Áõ½Ä(ҮدøÁüÀÐÉñòãÖ)
  • cell proliferation
    ¼¼Æ÷ Áõ½Ä
  • cell,proliferation
    Áõ½Ä(ñòãÖ)
  • lymphocyte proliferation
    ¸²ÇÁ±¸Áõ½Ä
  • massive periretinal proliferation<¿¾>=>PVR
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
  • proliferation phase
    Áõ½Ä±â(ñòãÖÑ¢).
  • proliferation zone
    Áõ½ÄÃþ
  • pseudoepitheliomatous proliferation
    °¡¼º»óÇÇÁ¾¼º Áõ½Ä
  • pseudosarcomatous proliferation
    °¡¼ºÀ°Á¾¼º Áõ½Ä(Ê£àõë¿ðþàõ ñòãÖ)
  • reactive pseudosarcomatous proliferation
    ¹ÝÀÀ¼º °¡¼ºÀ°Á¾¼º Áõ½Ä(¡­Ê£àõë¿ðþàõ)
  • zone of proliferation
    Áõ½ÄÃþ, Áõ½Ä´ë (ñòãÖÓá).
  • anti-extractable nuclear antigen
    Ç×-ÃßÃ⼺ ÇÙÇ׿ø
  • anulus of nuclear pore
    ÇÙ±¸¸ÛµÑ·¹
  • autonomous nuclear family
    ÀÚÀ²¼º ÇÙ°¡Á·.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Proliferation zone
    Áõ½ÄÃþ
    [¿¾ ¿ë¾î] Áõ½Ä´ë
  • External nuclear membrane
    ¹Ù±ùÇÙ¸·
    [¿¾ ¿ë¾î] ¿ÜÇÙ¸·
  • Outer nuclear layer
    ¹Ù±ùÇÙÃþ
    [¿¾ ¿ë¾î] ¿ÜÇÙÃþ
  • Internal nuclear membrane
    ¼ÓÇÙ¸·
    [¿¾ ¿ë¾î] ³»ÇÙ¸·
  • Inner nuclear layer
    ¼ÓÇÙÃþ
    [¿¾ ¿ë¾î] ³»ÇÙÃþ
  • Internal nuclear layer [Bipolar cell layer]
    ¼ÓÇÙÃþ [µÎ±Ø¼¼Æ÷Ãþ]
    [¿¾ ¿ë¾î] ³»ÇÙÃþ(À̱ؼ¼Æ÷Ãþ)
  • Nuclear pore
    ÇÙ±¸¸Û
    [¿¾ ¿ë¾î] ÇÙ°ø
  • Diaphragm of nuclear pore
    ÇÙ±¸¸Û°¡·Î¸·
    [¿¾ ¿ë¾î] ÇÙ°ø°Ý¸·
  • Anulus of nuclear pore
    ÇÙ±¸¸ÛµÑ·¹
    [¿¾ ¿ë¾î] ÇÙ°ø·û
  • Nuclear membrane
    ÇÙ¸·
    [¿¾ ¿ë¾î] ÇÙ¸·
  • Nuclear chain fiber
    Çٻ罽±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÙ¼â
  • Nuclear vesicle
    ÇÙ¼ÒÆ÷
    [¿¾ ¿ë¾î] ÇÙ¼ÒÆ÷
  • Nuclear saccule
    ÇÙÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÇÙ³¶
  • Nuclear saccule
    ÇÙÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÇÙ¼Ò³¶
  • Nuclear bag fiber
    ÇÙÁָӴϱÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÙ³¶
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fourier transform nuclear magnetic resonance
    Ǫ¸®¿¡ º¯È¯(ܨüµ) ÇÙÀÚ±â°ø¸í(ú·í¸Ñ¨ÍìÙ°)
  • heterogeneous nuclear RNA
    ÀÌÁú(ì¶òõ) ÇÙ(ú·)RNA
  • nuclear body
    ÇÙü(ú·ô÷)
  • nuclear column
    ÇÙ(ú·) Ä÷³
  • nuclear cycle
    ÇÙÁÖ±â(ú·ñÎÑ¢)
  • nuclear division
    Çٺп­(ú·ÝÂÖª)
  • nuclear duplication
    ÇÙº¹»ç(ú·ÜÜÞÐ)
  • nuclear emulsion
    ÇÙ(ú·)¿¡¸ÖÀü
  • nuclear envelope
    ÇÙ¸·(ú·Ø¯)
  • nuclear equivalent
    ÇÙ´çü(ú·Ó×ô÷)
  • nuclear fission
    Çٺп­(ú·ÝÂÖª)
  • nuclear fusion
    ÇÙÀ¶ÇÕ(ú·ë×ùê)
  • nuclear isomer
    ÇÙÀ̼ºÃ¼(ú·ì¶àõô÷)
  • nuclear magnetic resonance
    ÇÙÀÚ±â°ø¸í(ú·í¸ÐïÍìÙ°)
  • nuclear resonance scattering
    ÇÙ°ø¸íºÐ»ê(ú·ÍìÙ°ÝÂߤ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferation
    Áõ½Ä, ¹ø½Ä
  • net nuclear magnetization
    ÃÑÇÙÀÚ±âÈ­
  • nuclear
    ¡ì»ý¹°ÀÇ¡íÇÙÀÇ , ¿øÀÚÇÙÀÇ
  • nuclear division
    ¡ì¼¼Æ÷¡íÇٺп­
  • nuclear energy
    ÇÙ¿¡³ÊÁö
  • nuclear induction
    ÇÙÀ¯µµ
  • nuclear magnetic resonance [=NMR]
    ÇÙÀÚ±â°ø¸í
  • nuclear medicine
    ÇÙÀÇÇÐ
  • nuclear paramagnetic resonance
    ÇÙ»óÀÚ¼º°ø¸í
  • nuclear paramagnetism
    ÇÙ»óÀÚ¼º
  • nuclear power
    ÇÙ·Â
  • nuclear spin
    ÇÙ½ºÇÉ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NM near-miss; neomycin; neuromedin; neuromuscular; neutrophil migration; nictitating membrane; nitrogen...
PIF   1) Proliferation Inhibitory Factor
  2) Prolactin release Inhibiting Factor...
ALEP atypical lymphoepithelioid cell proliferation
DMP diffuse mesangial proliferation; dimercaprol; dimethylphthalate
EMP electric membrane property; electromagnetic pulse; Embden-Meyerhof pathway; external membrane potent...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCNA Proliferation Cell Nuclear Antigen
LPT Lymphocyte Proliferation Test
LP Lymphocyte proliferation
MPP Massive periretinal proliferation
PI Proliferation Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bone proliferation
    °ñ Áõ½Ä
  • proliferation phase
    Áõ½Ä±â
  • pseudosarcomatous proliferation
    °¡¼º À°Á¾¼º Áõ½Ä
  • free nuclear division
    À¯¸® ÇÙ ºÐ¿­
    ¼¼Æ÷Áúü ºÐ¿­À» ¼ö¹ÝÇÏÁö ¾Ê°í ÀÌ·ç¾îÁö´Â ÇÙ ºÐ¿­. ÀÚÀ¯ ÇÙ ºÐ¿­À̶ó°íµµ ÇÑ´Ù. À¯¸® ÇÙ ºÐ¿­ °á°ú ÀϽÃÀûÀ¸·Î ´ÙÇÙ ¼¼Æ÷°¡ Çü¼ºµÇÁö¸¸, ±× ÈÄ µ¿½Ã¿¡ ÇÙ »çÀÌ °Ýº®ÀÌ Çü¼ºµÇ¾î ´Ù¼öÀÇ ¼¼Æ÷·Î ºÐ¸®µÈ´Ù. °Ñ¾¾½Ä¹°ÀÇ ¹è Çü¼º, Á¾ÀÚ ½Ä¹°ÀÇ ¹èÁ¥ Çü¼º, °üÁ¶·ùÀÇ ¿µ¾çü µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. °ïÃæÀÇ ³­ÇÒ ÃʱâÀÇ °úÁ¤µµ À̰Ϳ¡ ÇØ´çÇÑ´Ù.
  • net nuclear magnetization
    ÃÑ ÇÙ ÀÚ±âÈ­
  • nuclear
    ÇÙÀÇ, ¿øÀÚ ÇÙÀÇ
  • nuclear antigen
    ÇÙ Ç׿ø
  • nuclear bag fiber
    ÇÙ ³¶ ¼¶À¯
  • nuclear bombardment
    ÇÙ Ãæµ¹
  • nuclear cataract
    ÇÙ ¹é³»Àå
  • nuclear charge
    ÇÙ ÇÏÀü
  • nuclear energy
    ÇÙ ¿¡³ÊÁö
  • nuclear fission
    ÇÙ ºÐ¿­
  • nuclear isomer
    ÇÙ À̼ºÃ¼
  • nuclear magnetic resonance
    ÇÙ Àڱ⠰ø¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
gingival proliferation Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells.
(12 Dec 1998)
regulatory cell proliferation kinase <enzyme> Involved in mitosis regulation; has characteristics of serine/threonine and tyrosine kinases; isolated from saccharomyces cerevisiae; genbank l08909
Registry number: EC 2.7.1.-
Synonym: rpk1 protein, rpk1 gene product
(26 Jun 1999)
cell proliferation <cell biology> Increase in cell number by division.
(26 Mar 1998)
proliferation <cell biology> The reproduction or multiplication of similar forms, especially of cells and morbid cysts.
Origin: L. Proles = offspring, ferre = to bear
(18 Nov 1997)
proliferation cyst A mother cyst containing daughter cyst's; a cyst with tumourous formation at one portion of the sac.
(05 Mar 2000)
proliferation therapy Rehabilitation of an incompetent structure (ligament or tendon) by the induced proliferation of new cells; accomplished by injecting an irritating substance into the loose ligament or tendon, the resulting scar formation and contracture serving to tighten up the ligament or tendon as scar tissue proliferates.
(05 Mar 2000)
diffuse mesangial proliferation <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome.
Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine.
Acronym: MPGN
(05 Jan 1998)
receptors, cytoplasmic and nuclear Proteins in the cytoplasm or nucleus that specifically bind signalling molecules and trigger changes which influence the behaviour of cells. The major groups are the steroid hormone receptors, which usually are found in the cytoplasm, and the thyroid hormone receptors, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands.
(12 Dec 1998)
Remak's nuclear division <cell biology> An unusual form of nuclear division, in which the nucleus simply constricts, rather like a cell without chromosome condensation or spindle formation. Partitioning of daughter chromosomes is haphazard. Observed in some Protozoa.
(18 Nov 1997)
Pelger-Huet nuclear anomaly Congenital inhibition of lobulation in the nuclei of neutrophilic leukocytes; most cells present band or bilobulate appearance, and only an occasional cell is trilobed; it is not associated with disease, but may be confused with leukocyte "shift to left"; autosomal dominant inheritance.
(05 Mar 2000)
ribonucleoproteins, small nuclear Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm. The u3 snrnp is localised in the nucleolus, where it aligns into base pairs with the 28s rrna precursor in a still unidentified region and functions in pre-rrna processing. The u7 snrnp aligns into base pairs with a conserved sequence in the 3'-end of histone pre-mRNA and is an essential cofactor for the cleavage that creates the mature nonadenylated 3'-end.
(12 Dec 1998)
RNA, heterogeneous nuclear Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesised and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnrna hybridises with nuclear DNA rather than with mRNA.
(12 Dec 1998)
RNA, nuclear RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm.
(12 Dec 1998)
RNA, small nuclear Short chains of RNA found in the nucleus. Their function is to remove the introns (nontranslated intervening sequences) from mRNA precursors, thereby bringing the two exons (coding segments) together into correct juxtaposition for enzymatic splicing at the correct point. The resulting mRNA is now ready to leave the nucleus.
(12 Dec 1998)
rod nuclear cell <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferation
    ºÐ¾Æ(ºÐ¿­) Áõ½Ä;°ÝÁõ;±ÞÁõ;È®»ên
  • Nuclear Regulatory Commission
    ¹Ì±¹ÀÇ ¿øÀÚ·Â ±ÔÁ¦ À§¿øÈ¸
  • nuclear
    (»ý)¼¼Æ÷ÇÙÀÇ;ÇÙÀ» Çü¼ºÇÏ´Â;¿øÀÚÇÙ·ÂÀÇ;¿øÀÚ¹«±âÀÇ;ÇÙ¹«±âÀÇ;ÇÙº¸À¯ÀÇ;ÇÙ½ÉÀÇ;ÁÖ¿äÇÑ;ÇÙ¹«±â;ÇÙº¸À¯±¹
  • nuclear bomb
    ÇÙÆøÅº
  • nuclear chemistry
    ÇÙÈ­ÇÐ
  • nuclear disarmament
    ÇÙ±ºÃà
  • nuclear energy
    ÇÙ ¿¡³ÊÁö !
  • nuclear failout
    ÇÙ Æø¹ß¿¡ ÀÇÇÑ ¹æ»ç´É ³«Áø
  • nuclear family
    ÇÙ°¡Á·
  • nuclear fission
    Çٺп­
  • nuclear force
    ÇÙ·Â
  • nuclear fuel
    ÇÙ¿¬·á
  • nuclear fusion
    ÇÙÀ¶ÇÕ
  • nuclear grapeshot
    (±º)¼ÒÇü Àü¼úÇÙ¹«±â
  • nuclear magnetic resonance
    (¹°)ÇÙÀڱ⠰ø¸í
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á